Join the 22nd Global Biomarkers and Clinical Research Summit 2026 & Contribute to Cardiovascular Diagnostics and Biomarkers (CDB)

2026-03-23

Dear Researchers, Clinicians, and Colleagues,

Warm greetings from the editorial office of Cardiovascular Diagnostics and Biomarkers (CDB)!

We are pleased to share that the 22nd Global Biomarkers and Clinical Research Summit 2026 will be held August 27–28, 2026, in Paris, France, with the theme “Translating Biomarker Discovery into Clinical Breakthroughs”. As a global flagship event for biomarker research and translational medicine, this summit gathers leading scientists, clinicians, and industry experts worldwide to share cutting‑edge advances in biomarker discovery, validation, omics technologies, digital biomarkers, clinical assay development, regulatory standards, and precision medicine. Cardiovascular diagnostics and biomarkers represent one of the most dynamic and clinically impactful themes of the summit.

We strongly encourage all investigators in cardiovascular science to attend, present original research, engage in academic exchanges, and expand international collaborations.

 

CDB Journal & Call for Papers

Cardiovascular Diagnostics and Biomarkers (CDB) is a newly launched open‑access journal dedicated to advancing biomarker development and diagnostic strategies for cardiovascular diseases. We welcome high‑quality, peer‑reviewed submissions covering:

  • Discovery and evaluation of circulating biomarkers for cardiovascular diseases.
  • Multi omics profiling for early detection, prognosis and disease stratification.
  • Diagnostic classifiers and molecular signatures for ischemia, heart failure and arrhythmia.
  • Point of care devices for rapid cardiac biomarker testing.
  • Integration of molecular profiles into clinical diagnostic pathways and algorithms.
  • Validation studies for emerging cardiovascular diagnostic assays.
  • Biomarker driven precision medicine and personalised cardiology approaches.
  • Translational research linking molecular findings to clinical decision making.

 

We welcome original research articles, reviews, systematic reviews, brief communications, and study protocols relevant to the scope above.

Journal homepage: https://journal.bytran-pub.com/index.php/CDB

We invite summit attendees and all researchers in the field to submit your impactful work to CDB. Selected high‑quality papers may be considered for fast‑track review and promotional support.

 

We look forward to your active participation in the Paris summit and valuable contributions to CDB. Together, we will promote innovation and translation in cardiovascular diagnostics and biomarkers.

Sincerely, 

Editorial Office 

Cardiovascular Diagnostics and Biomarkers (CDB)

E-mail: editorial-cdb@bytran-pub.com